Jun 13 – 19, 2015
University of Alberta
America/Edmonton timezone
Welcome to the 2015 CAP Congress! / Bienvenue au congrès de l'ACP 2015!

Cancer cell targeting gold nanoparticles for therapeutics

Jun 15, 2015, 4:00 PM
CCIS 1-160 (University of Alberta)

CCIS 1-160

University of Alberta

Oral (Student, In Competition) / Orale (Étudiant(e), inscrit à la compétition) Medical and Biological Physics / Physique médicale et biologique (DMBP-DPMB) M2-6 Radiation Therapy (DMBP-DNP) / Thérapie par rayonnement (DPMB-DPN)


Charmainne Cruje (Ryerson University)


Polyethylene glycol (PEG) has promoted the prospective cancer treatment applications of gold nanoparticles (GNPs). *In vivo* stealth of GNPs coated with PEG (PEG-GNPs) takes advantage of the enhanced permeability and retention effect in tumor environments, making them suitable for targeted treatment. Because PEG minimizes gold surface exposure, PEG-GNP interaction with ligands that mediate cancer cell uptake is lower than uncoated GNPs. Hence, the cellular uptake of PEG-GNPs is significantly lower than uncoated GNPs *in vitro*. As intracellular localization of GNPs maximizes its therapeutic enhancement, there is a need to improve the uptake of PEG-GNPs. To enhance uptake, receptor mediated endocytosis peptides were conjugated with PEG-GNPs of varying core sizes. Spherical GNPs of diameters 14 nm, 50 nm and 70 nm and a PEG chain length of 2 and 5 kDa were used to determine a preferred core size and chain length for uptake *in vitro* in HeLa and MDA-MB-231 cells. Radiosensitization of HeLa cells to a 6 MVp clinical photon beam via GNP conjugates were observed to assess its therapeutic application.

Primary author

Charmainne Cruje (Ryerson University)


Dr Devika Chithrani (Ryerson University)

Presentation materials

There are no materials yet.